NCT04681105 2026-01-28Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological MalignanciesCity of Hope Medical CenterPhase 1 Completed13 enrolled
NCT00408005 2025-04-20Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaNational Cancer Institute (NCI)Phase 3 Completed1,895 enrolled 16 charts